Capture
EPA TSCA risk dockets advance while SAB conflict waivers remain on file
Agency chemical evaluations under the Toxic Substances Control Act proceed in public dockets as Science Advisory Board members have received conflict-of-interest waivers, according to posted ethics forms, Federal Register notices, and Inspector General summaries of peer-review practice.
The Environmental Protection Agency continues to post risk-evaluation materials for existing chemicals under the 2016 amendments to the Toxic Substances Control Act. Those dockets, maintained on Regulations.gov, include draft scopes, systematic-review protocols, and peer-review charge questions. The record shows parallel activity at the Science Advisory Board, which EPA has used to review chemical assessments and related scientific products.
SAB members file confidential financial-disclosure reports and public ethics statements. Agency ethics officials have granted waivers under 18 U.S.C. 208(b)(1) and related EPA procedures when a member’s financial interest is judged not so substantial as to affect the integrity of the advice. Posted waiver letters and meeting minutes list the chemical or topic at issue and the nature of the recusal or limited participation. The documents do not describe classified deliberations.
Public comments in TSCA dockets have repeatedly flagged industry consulting, stock holdings, and prior employment among SAB and Chemical Safety Advisory Committee participants. Commenters have cited the same names that appear on waiver logs. EPA responses, also in the dockets, state that ethics reviews were completed and that members with conflicts recused from specific votes or discussions. The agency has not claimed that every financial tie was eliminated.
An EPA Office of Inspector General report on peer-review processes, issued after the 2016 TSCA amendments, examined whether the agency followed its own peer-review handbook and the Office of Management and Budget’s Final Information Quality Bulletin for Peer Review. The report noted instances in which conflict screening occurred after panel selection and recommended tighter timing. EPA concurred in part and described subsequent updates to SAB staff procedures. The IG did not allege criminal violations.
Federal Register notices for SAB meetings list agendas that include TSCA-related briefings. Attendance sheets and transcribed public comments show industry scientists, environmental groups, and academic researchers speaking to the same panels. Minutes record votes on draft letters to the administrator. Those letters, once transmitted, appear in both SAB archives and the relevant TSCA docket.
Budget justifications submitted to Congress show line items for TSCA implementation, including contractor support for systematic review and for SAB meeting logistics. The figures are public. They do not itemize individual waiver processing costs. Appropriations language has directed EPA to meet statutory deadlines for risk evaluations of high-priority chemicals. Deadlines have slipped; EPA has published revised schedules in the Federal Register.
Court dockets in challenges to specific risk evaluations—filed in the D.C. Circuit and other venues—cite both the scientific record and the composition of review panels. Petitioners have argued that waived conflicts undermine the appearance of impartiality. EPA briefs have replied that the statute requires the use of best available science and that ethics waivers are a recognized tool under government-wide conflict rules. Decisions remain pending in several cases; the agency has not withdrawn the evaluations at issue.
The Government Accountability Office has issued reports on EPA’s chemical program that discuss data gaps, peer-review quality, and workforce capacity. Those reports reference SAB input without reproducing individual waiver letters. GAO recommendations have focused on documentation and transparency of systematic-review methods rather than on the waiver statute itself.
SAB’s own policies, posted on the EPA website, require members to update disclosures when new interests arise. The policies also describe the process for requesting a waiver. Completed waivers are retained in ethics files and, in summarized form, made available for public meetings. The summaries typically omit dollar amounts and client names beyond what is already on financial-disclosure forms.
Industry trade associations have submitted comments supporting the continued use of experienced scientists, including those with prior consulting relationships, provided recusals are observed. Environmental organizations have filed comments arguing that waivers should be rare and that appearance of conflict should bar participation even when a legal waiver is available. Both sets of comments sit in the same public dockets as the draft risk evaluations.
EPA’s current administrator has, in congressional testimony transcribed in the Congressional Record, described TSCA implementation as a priority and stated that science advice is obtained through established advisory committees. The testimony did not address individual waivers by name. Committee questions have asked about industry influence; agency answers have pointed to ethics procedures and public comment opportunities.
The combination of open TSCA dockets and posted SAB ethics materials allows outside parties to compare the chemicals under review with the financial interests disclosed by reviewers. That comparison is already occurring in comments, IG work papers, and litigation exhibits. No public document obtained for this account is marked classified. The record that exists is the one EPA, the SAB, the IG, GAO, and the courts have placed in the open.